• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF FLAVONOIDS AND POLYPHENOLS (1000 SCIENTIFIC STUDIES)
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOECDYSTEROIDS
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    Piper longum
    January 15, 2020
    Sansalvamide A (MArine Fungi Fusarium)
    January 15, 2020

    Rottlerin (Asian tree Mallotus philippensis)

    1. … (BCR) cross-talk: the IL-4-induced alternate pathway for BCR signaling operates in parallel with the classical pathway, is sensitive to Rottlerin, and depends on Lyn
    2. … Receptor Crosstalk: The IL-4-induced Alternate Pathway for BCR Signaling Operates in Parallel with the Classical Pathway, Is Sensitive to Rottlerin, and Depends on …
    3. 303 ENHANCED THERAPY SUCCESS OF RENAL CELL CARCINOMA USING TYROSINE KINASE INHIBITORS COMBINED WITH ROTTLERIN
    4. 64PEffects of Rottlerin and genistein through EF2K on proliferation, invasion and cell cycle/death in neuroblastoma cells
    5. A polyphenolic compound Rottlerin demonstrates significant in vitro cytotoxicity against human cancer cell lines: isolation and characterization from the fruits of …
    6. AB161. Rottlerin-induced autophagy leads to the apoptosis in bladder cancer cells
    7. Abstract LB-011: PAK1 inhibitor FRAX1036 sensitizes ovarian cancer cells with amplified 11q13 to cytotoxic effect of rottlerin
    8. Activation of BKCa Channels With Rottlerin Greatly Improves Cardiac Functional Improvement Following Surgical Ischemia Associated With Cardioplegic Arrest.
    9. Alternative pathways of cancer cell death by rottlerin: apoptosis versus autophagy
    10. Anti-allergic actions of Rottlerin from Mallotus philippinensis in experimental mast cell-mediated anaphylactic models
    11. Antiproliferative effect of Rottlerin on SK-MEL-28 melanoma cells
    12. Arsenite-Stimulated Glucose Uptake in 3T3-L1 Adipocytes Is Sensitive to Inhibition by Rottlerin and Ro-31-8220
    13. Biosynthesis of promatrix metalloproteinase-9/chondroitin sulphate proteoglycan heteromer involves a Rottlerin-sensitive pathway
    14. Coadministration of sorafenib with Rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells
    15. Critical appraisal of the MTT assay in the presence of Rottlerin and uncouplers
    16. Design, synthesis and functional characterization of Rottlerin analogs
    17. Determination of rottlerin, a natural protein kinases C inhibitor, in pancreatic cancer cells and mouse xenografts by RP-HPLC method
    18. Development and validation of a RP-HPLC method for quantification of Rottlerin in Kamala (Mallotus philppinensis).
    19. Development and validation of a RP-HPLC method for the simultaneous determination of Embelin, Rottlerin and Ellagic acid in Vidangadi churna
    20. Down-regulation of caspase-2 by Rottlerin via protein kinase C-δ–independent pathway
    21. Down-regulation of Caspase-2 by Rottlerin via Protein Kinase CD–Independent Pathway
    22. Effect of rottlerin, a PKC-δ inhibitor, on TLR-4-dependent activation of murine microglia
    23. Effects of Rottlerin on in vitro proliferation of and expressions of interleukin-17C, CCL20 and nuclear factor-κB in a human keratinocyte cell line HaCaT
    24. Effects of Rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice
    25. Effects of rottlerin, an inhibitor of calmodulin-dependent protein kinase III, on cellular proliferation, viability, and cell cycle distribution in malignant glioma cells.
    26. Effects of Rottlerin, an Inhibitor of Calmodulin-dependent Protein Kinase Ill, on Cellular Proliferation, Viability, and Cell Cycle Distribution in Malignant Glioma …
    27. Efficient synthesis of Rottlerin and its two subunits
    28. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor Rottlerin and relative insensitivity towards staurosporine
    29. Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor Rottlerin and relative insensitivity towards staurosporine
    30. Expression of protein kinase c (pkc) isoforms and the effect of selective pkc-s inhibition by Rottlerin on the induction of apoptosis in acute promyelocytic leukemia
    31. Improved synergistic anticancer efficacy of quercetin in combination with PI-103, rottlerin, and G0 6983 against MCF-7 and RAW 264.7 cells
    32. Inhibition of amyloid fibril formation and disassembly of pre-formed fibrils by natural polyphenol rottlerin
    33. Inhibition of eukaryotic elongation factor-2 kinase mediates Rottlerin induced effects in apoptosis and cell proliferation inhibition in human pancreatic cancer cells.
    34. Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma cells
    35. Inhibitions of mTORC1 and 4EBP-1 are key events orchestrated by Rottlerin in SK-Mel-28 cell killing
    36. Integrated in Silico Docking and MOMA Simulation Methods Reveal Rottlerin as a Potent Janus kinase 2 (JAK2) Inhibitor
    37. Integrin signaling and cell spreading alterations by Rottlerin treatment of chick limb bud mesenchymal cells
    38. Kinase inhibitors tyrphostin 9 and Rottlerin block early steps of rabies virus cycle
    39. Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin
    40. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL
    41. Mechanisms of Rottlerin-mediated inhibition of chlamydial growth
    42. Mo1954 Rottlerin Promotes Apoptosis and Autophagy in Pancreatic Stellate Cells via AMPK Activation
    43. Multi-Functional Role of Rottlerin, PKC-Delta Inhibitor, in Immune Cells and Cancer Cells
    44. Multiple mechanisms of Rottlerin toxicity in A375 melanoma cells
    45. Neuroprotective effect of protein kinase Cδ inhibitor Rottlerin in cell culture and animal models of Parkinson’s disease
    46. Non-conventional Rottlerin anticancer properties
    47. NOX, RAS and PKC-Δ as Key Players in Kidney Diseases: A Possible Role of Rottlerin
    48. Phosphorylation-independent mTORC1 inhibition by the autophagy inducer Rottlerin
    49. Possible mechanism of Rottlerin induced modulation of ischemia reperfusion injury in isolated rat hearts
    50. Potent stimulation of large‐conductance Ca2+‐activated K+ channels by rottlerin, an inhibitor of protein kinase C‐δ, in pituitary tumor (GH3) cells and in cortical …
    51. Potential in for PKC inhibitor Rottlerin in murine experimental model of asthma
    52. Potentiation of tumor necrosis factor-α-induced cell death by Rottlerin through a cytochrome-c-independent pathway
    53. Prevention of TNF-induced necrotic cell death by Rottlerin through a Nox1 NADPH oxidase
    54. Protection of human colon epithelial cells against deoxycholate by rottlerin
    55. Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase
    56. Protein kinase C‐delta is commonly expressed in multiple myeloma cells and its downregulation by Rottlerin causes apoptosis
    57. Receptor Activator of Nuclear Factor-icB Is Induced by a Rottlerin-sensitive and p38 MAP Kinase-dependent Pathway during Monocyte Differentiation.
    58. Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation
    59. Research Article Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy
    60. Research Article Rottlerin Inhibits ROS Formation and Prevents NFκB Activation in MCF-7 and HT-29 Cells
    61. Reversal of the negative effects of TGFβ1 on human articular chondrocytes by PKCδ inhibition with rottlerin
    62. Rottlerin activates AMPK possibly through LKB1 in vascular cells and tissues
    63. Rottlerin and cancer: novel evidence and mechanisms
    64. Rottlerin and curcumin: a comparative analysis
    65. Rottlerin as a novel chemotherapy agent for adrenocortical carcinoma
    66. Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies
    67. Rottlerin causes pulmonary edema in vivo: a possible role
    68. Rottlerin causes pulmonary edema in vivo: a possible role for PKCδ
    69. Rottlerin Derivatives and Other Compounds from Mallotus philippinensis Fruits and Their Potential Antimycobactrial Activity
    70. Rottlerin diminished the lipid accumulation in 3T3-L1 cell line and enhanced the uncoupling of oxidative phosphorylation in D16 cell line via LRP6 mediated pathway
    71. Rottlerin dissolves pre-formed protein amyloid: A study on hen egg white lysozyme
    72. Rottlerin enhances IL-1β-induced COX-2 expression through sustained p38 MAPK activation in MDA-MB-231 human breast cancer cells
    73. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells
    74. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells
    75. Rottlerin Exhibits Antiangiogenic Effects In vitro
    76. Rottlerin exhibits antitumor activity via down-regulation of TAZ in non-small cell lung cancer
    77. Rottlerin greatly improves cardiac functional recovery following ischemic cardioplegic arrest (CP) in wild-type but not BKCa channel knockout mice
    78. Rottlerin impairs the formation and maintenance of psychostimulant-supported memory
    79. Rottlerin Increases Cardiac Contractile Performance and Coronary Perfusion Through BKCa++ Channel Activation After Cold Cardioplegic Arrest in Isolated Hearts
    80. Rottlerin induce early autophagy and late apoptosis via PKC-delta independent pathway.
    81. Rottlerin induced autophagy by targeting multiple sites that leads to the apoptosis in cancer stem cells
    82. Rottlerin induces a transformed phenotype in human keratinocytes
    83. Rottlerin induces apoptosis in pancreatic cancer cells through the interaction with Bcl-2 family proteins
    84. Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism
    85. Rottlerin induces apoptosis of human blood eosinophils: A possible role for PKC-[delta] in mediating eosinophil survival
    86. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC δ-independent mechanism in human malignant tumor cells
    87. Rottlerin Induces Apoptosis via Death Receptor5 (DR5) Up-Regulation through CHOP-Dependent and PKC d-Independent Mechanism in Human Malignant Tumor …
    88. Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway
    89. Rottlerin induces autophagy and apoptotic cell death through a PKC-delta-independent pathway in HT1080 human fibrosarcoma cells: the protective role of …
    90. Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells
    91. Rottlerin induces calcium influx and protein degradation in cultured lenses independent of effects on protein kinase Cδ
    92. Rottlerin induces cyclooxygenase-2 upregulation through an ATF4 and reactive oxygen species-independent pathway in HEI-OC1 cells
    93. Rottlerin induces ER stress-mediated cell death in pancreatic stellate cells
    94. Rottlerin induces heme oxygenase-1 (HO-1) up-regulation through reactive oxygen species (ROS) dependent and PKC δ-independent pathway in human colon …
    95. Rottlerin Induces Heme Oxygenase-1 through ROS generation, p38 and Akt Phosphorylation and Nrf2/ARE Activation in Human Colon Cancer HT29 Cells
    96. Rottlerin induces pro-apoptotic endoplasmic reticulum stress through the protein kinase C-δ-independent pathway in human colon cancer cells
    97. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells
    98. Rottlerin inhibitis agonist-stimulated tyrosine phosphorylation (TyrP), MAPK activation, and amylase secretion by depleting intracellular ATP in rat …
    99. Rottlerin Inhibits (Na+, K+)-ATPase Activity in Brain Tissue and Alters d-Aspartate Dependent Redistribution of Glutamate Transporter GLAST in Cultured Astrocytes
    100. Rottlerin inhibits (Na+, K+)-ATPase activity in brain tissue and alters D-Aspartate dependent redistribution of glutamate transporter GLAST in cultured astrocytes
    101. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells
    102. Rottlerin inhibits cell growth and invasion via down-regulation of EZH2 in prostate cancer
    103. Rottlerin inhibits cell growth, induces apoptosis and cell cycle arrest, and inhibits cell invasion in human hepatocellular carcinoma
    104. Rottlerin inhibits chlamydial intracellular growth and blocks chlamydial acquisition of sphingolipids from host cells
    105. Rottlerin inhibits human T cell responses
    106. Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation
    107. Rottlerin inhibits Lonicera japonica-induced photokilling in human lung cancer cells through cytoskeleton-related signaling cascade
    108. Rottlerin inhibits migration of follicular thyroid carcinoma cells by PKCδ‐independent destabilization of the focal adhesion complex
    109. Rottlerin inhibits migration of thyroid follicular carcinoma through destablization of the focal adhesion complex
    110. Rottlerin inhibits multiple steps involved in insulin-induced glucose uptake in 3T3-L1 adipocytes
    111. Rottlerin inhibits P2X7 receptor‐stimulated phospholipase D activity in chronic lymphocytic leukaemia B‐lymphocytes
    112. Rottlerin Inhibits ROS Formation and Prevents NF 𝜅 B Activation in MCF-7 and HT-29 Cells
    113. Rottlerin inhibits stimulated enzymatic secretion and several intracellular signaling transduction pathways in pancreatic acinar cells by a non-PKC-δ …
    114. Rottlerin inhibits the nuclear factor κB/Cyclin-D1 cascade in MCF-7 breast cancer cells
    115. Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCδ-independent fashion
    116. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP
    117. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cδ tyrosine phosphorylation
    118. Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells
    119. Rottlerin Mediated Modulation of Tonicity-Responsive Enhancer Binding Protein (TonEBP) In Wistar Rats
    120. Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I …
    121. Rottlerin promotes apoptosis and autophagy in pancreatic stellate cells via AMPK activation
    122. Rottlerin promotes autophagy and apoptosis in gastric cancer cell lines
    123. Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCδ phosphorylation
    124. Rottlerin Reduces cAMP/CREB-Mediated Melanogenesis via Regulation of Autophagy
    125. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria …
    126. Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP
    127. Rottlerin stimulates apoptosis in pancreatic cancer
    128. Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family
    129. Rottlerin stimulates apoptosis in pancreatic cancer through inhibition of Bcl-xL
    130. Rottlerin stimulates metallothionein gene expression but inhibits metal transport in Chinese hamster ovary cells
    131. Rottlerin Suppresses Airway Hyperreactivity And Inflammation In Mouse Models Of Experimental Asthma
    132. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from KrasG12D mice
    133. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein …
    134. Rottlerin upregulates DDX3 expression in hepatocellular carcinoma
    135. Rottlerin-independent attenuation of pervanadate-induced tyrosine phosphorylation events by protein kinase C-δ in hemopoietic cells
    136. Rottlerin-induced autophagy leads to apoptosis in bladder cancer cells
    137. Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
    138. Rottlerin-induced BKCa channel activation impairs specific contractile responses and promotes vasodilation
    139. Rottlerin-mediated inhibition of Chlamydia trachomatis growth and uptake of sphingolipids is independent of p38-regulated/activated protein kinase (PRAK)
    140. Rottlerin-mediated inhibition of Toxoplasma gondii growth in BeWo trophoblast-like cells
    141. Rottlerin, a novel protein kinase inhibitor
    142. Rottlerin, a PKC isozyme‐selective inhibitor, affects signaling events and cytokine production in human monocytes
    143. Rottlerin, a PKC-delta Inhibitor, Strongly Suppresses Cell Cycle Progression in Vascular Smooth Muscle Cell Through AMPK Activation.
    144. Rottlerin, a polyphenolic compound from the fruits of Mallotus phillipensis (Lam.) Müll. Arg., impedes oxalate/calcium oxalate induced pathways of oxidative stress in …
    145. Rottlerin, a specific inhibitor of protein kinase C-delta, impedes barrier repair response by increasing intracellular free calcium
    146. Rottlerin, an inhibitor of protein kinase Cδ (PKCδ), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to …
    147. Rottlerin: a multifaced regulator of keratinocyte cell cycle
    148. Rottlerin: An antibacterial agent and inhibitor of plasmid-mediated antibiotic resistance transfer
    149. Rottlerin: an inappropriate and ineffective inhibitor of PKCδ
    150. Rottlerin: bases for a possible usage in psoriasis
    151. SALUBRIOUS EFFECT OF Rottlerin ON HYPEROXALURIA INDUCED OXIDATIVE DAMAGE IN RATS
    152. Selective inhibition by Rottlerin of macropinocytosis in monocyte‐derived dendritic cells
    153. Semisynthesis of mallotus B from rottlerin: evaluation of cytotoxicity and apoptosis-inducing activity
    154. Sorafenib in combination with Rottlerin show an additive effects in renal cell carcinoma (RCC) cells.
    155. Statin and Rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1
    156. Stimulation of suicidal erythrocyte death by Rottlerin
    157. Sustained Release of Rottlerin Encapsulated within Poly (D, L-Lactic-co-Glycolic Acid) Nanoparticles Inhibits Migration and Clonogenicity in Pancreatic Cancer Cells
    158. Synergism between PKCδ regulators hypericin and Rottlerin enhances apoptosis in U87 MG glioma cells after light stimulation
    159. The effect of PKC-delta inhibitor Rottlerin on human colon cancer cell line SW1116 and its mechanism
    160. The effect of Rottlerin in calcium regulation in HMC‐1560 cells is mediated by a PKC‐δ independent effect
    161. The Group I Pak inhibitor Frax-1036 sensitizes 11q13-amplified ovarian cancer cells to the cytotoxic effects of Rottlerin
    162. The Link between rottlerin, Na+, K+-ATPase activity and Na+-dependent glutamate transport
    163. The mechanisms of proapoptotic effects of Rottlerin in pancreatic cancer cells involve interaction with Bcl-2 protein
    164. The mosaic of rottlerin
    165. The Mosaic of Rottlerin: The Sequel
    166. The natural plant product Rottlerin activates Kv7. 1/KCNE1 channels
    167. The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases’ cascade
    168. The PKC delta inhibitor; rottlerin; induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases’ cascade
    169. The protein kinase C delta inhibitor Rottlerin greatly stimulates apoptosis in pancreatic cancer cells
    170. Therapeutic potential of Rottlerin for skin hyperpigmentary disorders by inhibiting the transcriptional activity of CREB-regulated transcription coactivators
    171. Tumor suppressive role of Rottlerin in cancer therapy
    172. Use of Rottlerin and its derivatives as activators of BK channel for therapy of hypertension and related disorders
    Share
    0
    INTERSTELLAR BLEND
    INTERSTELLAR BLEND

    Related posts

    February 20, 2020

    Wedelolactone


    Read more
    February 20, 2020

    Trichostatin A


    Read more
    February 20, 2020

    Taraxasterol


    Read more

    Comments are closed.

    Recent Posts

    • ANTI COVID-19 EFFECTS OF FLAVONOIDS AND POLYPHENOLS (1000 SCIENTIFIC STUDIES)
    • Myostatin Inhibition Preserves Muscle
    • Myostatin inhibition and Muscle growth
    • Phytoecdysteroids
    • PPARY2
    © 2021 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!